Incidence and prognostic significance of C-MPL expression in acute myeloid leukemia

被引：9

作者：

Chelvatheebam, S

Langabeer, SE

Linch, DC

Hills, RK

Greenwell, P

机构：

[1] UCL, Dept Hematol, London WC1E 6HX, England

[2] Univ Birmingham, Clin Trials Unit, Birmingham B15 2RR, W Midlands, England

[3] Univ Westminster, Sch Biosci, London W1W 6UW, England

来源：

LEUKEMIA RESEARCH | 2003年 / 27卷 / 09期

关键词：

D O I：

10.1016/S0145-2126(03)00016-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：869 / 870

页数：2

共 9 条

[1]

Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia [J].

Albitar, M ;

Manshouri, T ;

Kantarjian, H ;

Keating, M ;

Estrov, Z ;

Faber, J ;

Freireich, EJ ;

Pierce, S ;

Estey, E .

LEUKEMIA RESEARCH, 1999, 23 (01) :63-69

[2]

Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders [J].

Duensing, S ;

Duensing, A ;

Meran, JG ;

Kreft, A ;

Büsche, G ;

Ganser, A ;

Georgii, A .

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1999, 52 (03) :146-150

[3]

The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].

Grimwade, D ;

Walker, H ;

Oliver, F ;

Wheatley, K ;

Harrison, C ;

Harrison, G ;

Rees, J ;

Hann, I ;

Stevens, R ;

Burnett, A ;

Goldstone, A .

BLOOD, 1998, 92 (07) :2322-2333

[4]

Kaban K, 2000, CANCER, V88, P570, DOI 10.1002/(SICI)1097-0142(20000201)88:3<570::AID-CNCR12>3.0.CO

[5]

2-I

[6]

Analysis of thrombopoietin receptor (c-mpl) mRNA expression in de novo acute myeloid leukemia [J].

Schröder, JK ;

Kolkenbrock, S ;

Tins, J ;

Kasimir-Bauer, S ;

Seeber, S ;

Schütte, J .

LEUKEMIA RESEARCH, 2000, 24 (05) :401-409

[7]

Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy [J].

Wetzler, M ;

Baer, MR ;

Bernstein, SH ;

Blumenson, L ;

Stewart, C ;

Barcos, M ;

Mrozek, K ;

Block, AMW ;

Herzig, GP ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2262-2268

[8]

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial [J].

Wheatley, K ;

Burnett, AK ;

Goldstone, AH ;

Gray, RG ;

Hann, IM ;

Harrison, CJ ;

Rees, JKH ;

Stevens, RF ;

Walker, H .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) :69-79

[9]

Megakaryocyte c-Mp1 expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates [J].

Yoon, SY ;

Li, CY ;

Tefferi, A .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (03) :170-174

← 1 →